Sanofi India Limited (BOM:500674)
India · Delayed Price · Currency is INR | Market Cap | 75.61B -30.9% |
| Revenue (ttm) | 18.22B -5.7% |
| Net Income | 3.65B +2.4% |
| EPS | 158.27 +2.4% |
| Shares Out | 23.03M |
| PE Ratio | 20.74 |
| Forward PE | 18.48 |
| Dividend | 123.00 (3.75%) |
| Ex-Dividend Date | Nov 5, 2026 |
| Volume | 2,175 |
| Open | 3,320.00 |
| Previous Close | 3,379.40 |
| Day's Range | 3,267.25 - 3,342.25 |
| 52-Week Range | 2,758.30 - 4,776.00 |
| Beta | 0.11 |
| Analysts | Buy |
| Price Target | 4,339.67 (+32.19%) |
| Earnings Date | Oct 29, 2026 |
About Sanofi India
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also expor... [Read more]
Financial Performance
In 2025, Sanofi India's revenue was 18.37 billion, a decrease of -8.73% compared to the previous year's 20.13 billion. Earnings were 3.27 billion, a decrease of -20.99%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for 500674 stock is "Buy." The 12-month stock price target is ₹4,340, which is an increase of 32.19% from the latest price.
News
Sanofi India Quarterly report: Q3 2026
Sanofi India has published its Q3 2026 quarterly earnings report on October 28, 2026.
Sanofi India Earnings Call Transcript: Q2 2026
Q2 2026 saw strong double-digit growth in the diabetes segment, margin expansion, and a 34% increase in cash reserves. Partnership and export businesses faced headwinds, but strategic transformation and public sector expansion supported overall performance.
Sanofi India Quarterly report: Q2 2026
Sanofi India has published its Q2 2026 quarterly earnings report on August 5, 2026.
Sanofi India Slides: Q2 2026
Sanofi India has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
Sanofi India Quarterly report: Q1 2026
Sanofi India has published its Q1 2026 quarterly earnings report on April 29, 2026.
Sanofi India Earnings Call Transcript: Q4 2025
Transformation year saw flat domestic sales but 1% profit growth, with diabetes segment leading and partnership sales volatile due to inventory effects. Dividend per share proposed at INR 123, up 5%. Focus remains on diabetes, insulin, and operational efficiency.
Sanofi India Annual report: Q4 2025
Sanofi India has published its Q4 2025 annual report on February 26, 2026.
Sanofi India Quarterly report: Q4 2025
Sanofi India has published its Q4 2025 quarterly earnings report on February 26, 2026.
Sanofi India Slides: Q4 2025
Sanofi India has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 26, 2026.
Sanofi India Earnings Call Transcript: Q3 2025
Business transformation focused on diabetes and insulin drove margin expansion and operational efficiency, with double-digit profit growth and improved OpEx ratios. Export sales declined due to site divestment but are being offset by new markets. Interim dividend of INR 75 per share declared.
Sanofi India Quarterly report: Q3 2025
Sanofi India has published its Q3 2025 quarterly earnings report on October 29, 2025.
Sanofi India Slides: Q3 2025
Sanofi India has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 29, 2025.
Sanofi India Q2 Results: Revenue falls 9.3% YoY to Rs 475.4 crore, net profit down 7.5%
Sanofi India Limited reported its financial results for the quarter ended September 30, 2025, showing steady operational performance. Revenue from...
Sanofi India appoints Deepak Arora as new Managing Director, effective October 27, 2025
Sanofi India Limited (SIL) has appointed Deepak Arora as its new Managing Director, effective October 27, 2025, following the recommendation...
Sanofi India shares fall over 2% as Q1 revenue drops 12.4% YoY to Rs 406 crore, Ebitda down 18%
Sanofi India shares slipped more than 2% in early trade on Friday after the pharmaceutical major posted disappointing Q1 results for the financial year. The company’s revenue and operating margins dec...
Sanofi India Quarterly report: Q2 2025
Sanofi India has published its Q2 2025 quarterly earnings report on July 31, 2025.
Emcure and Sanofi India announce exclusive partnership to distribute oral anti-diabetic drugs in India
Emcure Pharmaceuticals Ltd. and Sanofi India Ltd. (SIL) have announced an exclusive distribution and promotion agreement for Sanofi’s oral anti-diabetic (OAD) products in India, effective immediately....
Sanofi India shares jumpo over 2% following Q4 FY25 Results
Sanofi India reported a mixed set of numbers for the March quarter, with a notable improvement in operational performance offsetting a decline in net profit. For Q4 FY25, net profit fell 12.5% year-on...
Sanofi India Quarterly report: Q1 2025
Sanofi India has published its Q1 2025 quarterly earnings report on May 14, 2025.
Sanofi India shares surge 6% on Q4 results; Rs 117 final dividend recommendation
Sanofi India Ltd. saw a strong uptick in its stock price on Friday, rising 6.04% to ₹5,288.30, following the announcement of its Q4 financial results. The stock traded within a day range of ₹5,009.00 ...
Sanofi India Recommends Rs 117 per share final dividend for Q4
Sanofi India Limited has recommended a final dividend of ₹117 per equity share of face value ₹10 for the financial year ended December 31, 2024. The dividend is subject to approval at the 69th Annual ...
Sanofi India Q4 Results: Net Profit declines 33.7% YoY, Revenue up 9.7% to Rs 514.9 crore
Sanofi India Limited has announced its Q4 financial results, reporting a 33.7% YoY decline in net profit to ₹91.3 crore, compared to ₹137.7 crore in the same period last year. Meanwhile, revenue incre...
Sanofi India Annual report: Q4 2024
Sanofi India has published its Q4 2024 annual report on February 26, 2025.
Sanofi India Quarterly report: Q4 2024
Sanofi India has published its Q4 2024 quarterly earnings report on February 26, 2025.
Stocks hitting 52-week low today, February 21: Sanofi India, Tata Communications, Star Health and more
The Indian stock market continued its downward trend for the fourth consecutive session on February 21, 2024. Both the Sensex and Nifty 50 ended in negative territory, reflecting bearish investor sent...